6533b827fe1ef96bd12865b5

RESEARCH PRODUCT

Photo-Cross-Linked Hydrogels with Polysaccharide−Poly(amino acid) Structure:  New Biomaterials for Pharmaceutical Applications

Fabio Salvatore PalumboGaetano GiammonaGiovanna PitarresiPaola PierroGiuseppe Tripodo

subject

Time FactorsPolymers and PlasticsUltraviolet RaysChemistry PharmaceuticalMolecular Sequence DataMethacrylic anhydrideBiocompatible MaterialsBioengineeringmacromolecular substancesBiomaterialschemistry.chemical_compoundPolysaccharidesPolymer chemistryCarbohydrate ConformationMaterials ChemistryAmino Acidschemistry.chemical_classificationAqueous solutionChemistrytechnology industry and agricultureChemical modificationHydrogelsAmino acidCarbohydrate Sequencebiomaterials drug delivery hyaluronic acidDrug deliverySelf-healing hydrogelsLiberationDrug carrierNuclear chemistry

description

The aim of this work has been the preparation and characterization of novel hydrogels with polysaccharide-poly(amino acid) structure having suitable physicochemical properties for pharmaceutical applications. In the first step, hyaluronic acid (HA) and alpha,beta-poly(N-2-hydroxyethyl)-DL-aspartamide (PHEA) have been derivatized with methacrylic anhydride (AMA), thus obtaining HA-AMA and PHM derivatives, respectively. In the second step, aqueous solutions of both these derivatives have been irradiated at 313 nm to obtain chemical hydrogels. The hydrogel obtained by irradiating for 15 min an aqueous solution containing 4% w/v of HA-AMA and 4% w/v of PHM resulted in the highest yield. Its swelling ability was dependent on the pH and nature of the external medium. Besides, this hydrogel undergoes a partial hydrolysis, especially in the presence of enzymes, such as esterase or hyaluronidase, but the entity of this degradation is lower than that observed for a hydrogel based on HA-AMA alone. The ability of this hydrogel to entrap drug molecules has been evaluated by using thrombin as a model drug. In vitro release studies and a platelet aggregation test demonstrated that the HA-AMA/PHM hydrogel is able to release thrombin in the active form, thus suggesting its suitability for the treatment of hemorrhages.

https://doi.org/10.1021/bm050697m